WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Relay Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian AdamsChief Legal Officer2025-03-27298$2.84
$846.32Sell
Thomas CatinazzoChief Financial Officer2025-03-274,566$2.84
$12.97kSell
Thomas CatinazzoChief Financial Officer2025-03-27298$2.84
$846.32Sell
Donald A. BergstromPresident RD2025-03-27986$2.84
$2.80kSell
Peter RahmerChief Corporate Development Officer2025-03-27247$2.84
$701.48Sell
Sanjiv PatelPresident and CEO2025-02-1375,324$3.70
$278.70kSell
Sanjiv PatelPresident and CEO2025-02-11140,182$3.85
$539.70kSell
Peter RahmerChief Corporate Development Officer2025-01-3017,250$4.42
$76.25kSell
Brian AdamsChief Legal Officer2025-01-3020,791$4.42
$91.90kSell
Thomas CatinazzoChief Financial Officer2025-01-3020,791$4.42
$91.90kSell

1 of 7

RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLAY insiders and whales buy or sell their stock.

RLAY Shareholders

What type of owners hold Relay Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Svf Pauling Cayman Ltd16.46%27,904,963$75.06MInsider
Sb Investment Advisers Uk Ltd16.46%27,904,963$75.06MInstitution
Vanguard Group Inc8.87%15,030,209$40.43MInstitution
Blackrock Inc8.66%14,674,262$39.47MInstitution
Third Rock Ventures III LP6.22%10,551,115$28.38MInsider
Casdin Capital LLC5.28%8,948,574$24.07MInstitution
Tang Capital Management LLC4.76%8,068,058$21.70MInstitution
Bellevue Group Ag4.35%7,377,292$19.84MInstitution
Norges Bank3.41%5,781,878$15.55MInstitution
State Street Corp3.11%5,279,726$14.20MInstitution

1 of 3

RLAY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLAY77.23%22.77%Net SellingNet Selling
STOK47.97%52.03%Net SellingNet Selling
FTRE99.67%0.33%Net SellingNet Selling
CGEM62.12%37.88%Net BuyingNet Selling
SAGE69.58%30.42%Net SellingNet Selling
View Top Biotech Stocks

Relay Therapeutics Stock Ownership FAQ

Who owns Relay Therapeutics?

Relay Therapeutics (NASDAQ: RLAY) is owned by 96.73% institutional shareholders, 28.53% Relay Therapeutics insiders, and 0.00% retail investors. Svf Pauling Cayman Ltd is the largest individual Relay Therapeutics shareholder, owning 27.90M shares representing 16.46% of the company. Svf Pauling Cayman Ltd's Relay Therapeutics shares are currently valued at $76.74M.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.